<h2>Question</h2>
<div class='specification'>
<p>Radioactive isotopes are used in a variety of medical procedures including medical imaging and radiotherapy.</p>
</div>

<div class='question' style='padding-left: 20px; padding-right: 20px;'>
<p>Lead-212 is a radioisotope that is used in the treatment of cancer. It is produced from another radioisotope by alpha decay. Formulate the equation for its production.</p>
<div class='marks'>[2]</div>
<div class='question_part_label'>b.</div>
</div>
<div class='question' style='padding-left: 20px; padding-right: 20px;'>
<p>Identify <strong>one</strong> advantage of using Targeted Alpha Therapy (TAT) and one form of cancer commonly treated by this method.</p>
<p>Advantage:<br /><br /></p>
<p>Cancer treatment:<br />&nbsp;</p>
<div class='marks'>[2]</div>
<div class='question_part_label'>c.</div>
</div>
<div class='question' style='padding-left: 20px; padding-right: 20px;'>
<p>Technetium-99m, used for radioimaging scans, has a half-life of 6.01 hours. Calculate the mass of a 5.80&times;10<sup>&minus;9</sup> g dose remaining after 24.04 hours.</p>
<div class='marks'>[2]</div>
<div class='question_part_label'>d.</div>
</div>
<div class='question' style='padding-left: 20px; padding-right: 20px;'>
<p>Outline an ethical implication of using nuclear treatments in medicine.</p>
<div class='marks'>[1]</div>
<div class='question_part_label'>e.</div>
</div>
<h2 style='margin-top: 1em'>Markscheme</h2>
<div class='question' style='padding-left: 20px;'>
<p>\({}_{84}^{216}{\rm{Po}} \to {}_2^4{\rm{He + }}{}_{82}^{212}{\rm{Pb}}\)<br />correct reactant<br />correct alpha particle</p>
<p><em>Atomic numbers not required for mark.</em><br /><em>Accept &ldquo;&alpha;&rdquo;/&ldquo;\({}_2^4\alpha \)&rdquo; for &ldquo;\({}_2^4{\rm{He}}\)&rdquo;.</em></p>
<div class='question_part_label'>b.</div>
</div>
<div class='question' style='padding-left: 20px;'>
<div class="page" title="Page 31">
<div class="section">
<div class="layoutArea">
<div class="column">
<p><em>Advantage</em>:<br />selectively kills cancer cells/targets cancer cells only<br /><em><strong>OR</strong></em><br />does not damage healthy cells</p>
<div class="page" title="Page 31">
<div class="section">
<div class="layoutArea">
<div class="column">
<p><em>Do <strong>not</strong> accept &ldquo;targets cancer&rdquo;. Reference must be made to &ldquo;cells&rdquo;.</em></p>
</div>
</div>
</div>
</div>
<p><em>Cancer treatment:<br /></em>melanoma<br /><em><strong>OR</strong></em><br />leukemia<br /><em><strong>OR</strong></em><br />rectal<br /><em><strong>OR</strong></em><br />breast<br /><em><strong>OR</strong></em><br />ovarian<br /><em><strong>OR</strong></em><br />prostate<br /><em><strong>OR</strong></em><br />pancreatic<br /><em><strong>OR</strong></em><br />cancers that spread around the body/produce metastasis/dispersed cancers</p>
<p><em>Accept &ldquo;skin cancer&rdquo;.</em></p>
</div>
</div>
</div>
</div>
<div class='question_part_label'>c.</div>
</div>
<div class='question' style='padding-left: 20px;'>
<p><em><strong>ALTERNATIVE 1:</strong></em><br />\(\lambda&nbsp; \ll&nbsp; = \frac{{\ln 2}}{{6.01}} \gg&nbsp; \approx 0.115 \ll {{\rm{h}}^{ - 1}} \gg \)<br />&laquo;remaining mass = 5.80&times;10<sup>-9</sup>&times;e<sup>-0.115 &times; 24.04</sup>=&raquo;3.63&times;10<sup>-10</sup> &laquo;g&raquo;</p>
<p><em><strong>ALTERNATIVE 2:</strong></em><br />\( \ll \frac{{24.04}}{{6.01}} =&nbsp; \gg 4 \ll {\rm{half lives}} \gg \)<br />\( \ll \frac{{5.80 \times {{10}^{ - 9}}}}{{{2^4}}} =&nbsp; \gg 3.63 \times {10^{ - 10}} \ll {\rm{g}} \gg \)</p>
<p><em>Award <strong>[2]</strong> for correct final answer.</em></p>
<div class='question_part_label'>d.</div>
</div>
<div class='question' style='padding-left: 20px;'>
<div class="page" title="Page 32">
<div class="section">
<div class="layoutArea">
<div class="column">
<p>risk vs benefit <strong>&laquo;</strong>patient and environment<strong>&raquo;<br /><em>OR</em></strong><br />providing adequate information to patients about risks<br /><em><strong>OR</strong></em><br />security concerns if nuclear radioactive material ended up with terrorists<br /><em><strong>OR</strong></em><br />cultural resistance/superstition/lack of education<br /><em><strong>OR</strong></em><br /><strong>&laquo;</strong>potential<strong>&raquo;</strong> exposure of health workers <strong>&laquo;</strong>to radioactivity<strong>&raquo;</strong><br /><em><strong>OR</strong></em><br />proper training &laquo;in radioactive hazards&raquo; not always given to workers<br /><em><strong>OR</strong></em><br />proper disposal of radioactive materials</p>
<div class="page" title="Page 32">
<div class="section">
<div class="layoutArea">
<div class="column">
<p><em>Accept other valid ethical implications (note that risk of cancer to the patient is not an ethical issue, while risk of cancer to the health worker is).</em></p>
<p><em>Do <strong>not</strong> accept &ldquo;security concerns&rdquo; alone &ndash; there must be some reference to an ethical implication.</em></p>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
<div class='question_part_label'>e.</div>
</div>
